Literature DB >> 16131418

Cognitive impairment and dementia in basal ganglia disorders.

Julie C Stout1, Shannon A Johnson.   

Abstract

We present an update focusing on research from the past 2 years on cognitive impairment and dementia in basal ganglia disorders, including Huntington's disease, progressive supranuclear palsy, Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. In addition to the many recent papers that aim to refine descriptions of the cognitive phenotypes in the basal ganglia disorders, the current literature addresses the use of cognitive assessment in differential diagnosis of clinically overlapping disorders, the effects of surgical and pharmacologic treatments on cognitive functions, and the relationship between cognitive impairment and functional disability. We also discuss opportunities for enhancing the understanding of cognition in basal ganglia disorders through the use of improved study design and assessment strategies.

Entities:  

Mesh：

Year:  2005        PMID： 16131418     DOI： 10.1007/s11910-005-0059-3

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


  48 in total

1.  Parkinson's disease dementia--a first step?

Authors:  Daniel Z Press
Journal:  N Engl J Med       Date:  2004-12-09       Impact factor: 91.245

2.  Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy.

Authors:  P Soliveri; D Monza; D Paridi; F Carella; S Genitrini; D Testa; F Girotti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

3.  Enhanced negative priming in Parkinson's disease.

Authors:  Scott A Wylie; Julie C Stout
Journal:  Neuropsychology       Date:  2002-04       Impact factor: 3.295

4.  Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both.

Authors:  M L Kraybill; E B Larson; D W Tsuang; L Teri; W C McCormick; J D Bowen; W A Kukull; J B Leverenz; M M Cherrier
Journal:  Neurology       Date:  2005-06-28       Impact factor: 9.910

5.  Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.

Authors:  Sid Gilman; Robert A Koeppe; Roderick Little; Hyonggin An; Larry Junck; Bruno Giordani; Carol Persad; Mary Heumann; Kris Wernette
Journal:  Exp Neurol       Date:  2005-02       Impact factor: 5.330

6.  Evidence for impaired encoding and retrieval memory profiles in Parkinson disease.

Authors:  Daniel Weintraub; Paul J Moberg; William C Culbertson; John E Duda; Matthew B Stern
Journal:  Cogn Behav Neurol       Date:  2004-12       Impact factor: 1.600

7.  Effects of levodopa on cognitive functioning in moderate-to-severe Parkinson's disease (MSPD).

Authors:  C E Morrison; J C Borod; M F Brin; T D Hälbig; C W Olanow
Journal:  J Neural Transm (Vienna)       Date:  2004-05-12       Impact factor: 3.575

8.  A comparison of episodic memory deficits in neuropathologically-confirmed Dementia with Lewy bodies and Alzheimer's disease.

Authors:  Joanne M Hamilton; David P Salmon; Douglas Galasko; Dean C Delis; Lawrence A Hansen; Eliezer Masliah; Ronald G Thomas; Leon J Thal
Journal:  J Int Neuropsychol Soc       Date:  2004-09       Impact factor: 2.892

9.  Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies.

Authors:  Atsuko Nagano-Saito; Takashi Kato; Yutaka Arahata; Yukihiko Washimi; Akinori Nakamura; Yuji Abe; Takako Yamada; Katsushige Iwai; Kentaro Hatano; Yasuhiro Kawasumi; Teruhiko Kachi; Alain Dagher; Kengo Ito
Journal:  Neuroimage       Date:  2004-06       Impact factor: 6.556

10.  The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study.

Authors:  Thomas Foltynie; Carol E G Brayne; Trevor W Robbins; Roger A Barker
Journal:  Brain       Date:  2003-12-22       Impact factor: 13.501
View more
  6 in total

Review 1.  Choosing an animal model for the study of Huntington's disease.

Authors:  Mahmoud A Pouladi; A Jennifer Morton; Michael R Hayden
Journal:  Nat Rev Neurosci       Date:  2013-10       Impact factor: 34.870

2.  Mild cognitive impairment in prediagnosed Huntington disease.

Authors:  K Duff; J Paulsen; J Mills; L J Beglinger; D J Moser; M M Smith; D Langbehn; J Stout; S Queller; D L Harrington
Journal:  Neurology       Date:  2010-07-07       Impact factor: 9.910

3.  Progressive obtundation in a young woman with bilateral corpus striatum infarction: a case report.

Authors:  Osama Sm Amin; Sa'ad Seud Shwani; Hero M Zangana; Nawa A Ameen
Journal:  J Med Case Rep       Date:  2011-07-25

Review 4.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

5.  Cognitive deficits in Huntington's disease on the Repeatable Battery for the Assessment of Neuropsychological Status.

Authors:  Kevin Duff; Leigh J Beglinger; Danielle Theriault; Jessica Allison; Jane S Paulsen
Journal:  J Clin Exp Neuropsychol       Date:  2009-05-29       Impact factor: 2.475

6.  Multidimensional Apathy: The Utility of the Dimensional Apathy Scale in Huntington's Disease.

Authors:  Kelly J Atkins; Sophie C Andrews; Trevor T-J Chong; Julie C Stout
Journal:  Mov Disord Clin Pract       Date:  2021-02-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.